IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
Cancers | Free Full-Text | Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors | PNAS
Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells: Molecular Therapy - Nucleic Acids
Frontiers | Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling | Circulation Research
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Sotorasib for Lung Cancers with KRAS p.G12C Mutation | NEJM
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells: Cell
Frontiers | The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures
Cancers | Free Full-Text | KRAS G12C Mutations in NSCLC: From Target to Resistance
Targeting Mutant KRAS for Immunogenic Cell Death Induction: Trends in Pharmacological Sciences
The current state of the art and future trends in RAS-targeted cancer therapies | Nature Reviews Clinical Oncology
Development and Preclinical Evaluation of Radiolabeled Covalent G12C-Specific Inhibitors for Direct Imaging of the Oncogenic KRAS Mutant | Molecular Pharmaceutics
KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition - eBioMedicine
JCM | Free Full-Text | KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
KRAS - Wikipedia
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Targeted Therapies Are Game Changers for Lung Cancer Patients with a KRAS Mutation | Fox Chase Cancer Center - Philadelphia PA
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) - ScienceDirect
KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences
Partnership seeks to develop KRAS degraders for cancer therapy | Frederick National Laboratory
